NASDAQ:DERM Journey Medical (DERM) Stock Price, News & Analysis $7.55 +0.26 (+3.57%) Closing price 10/7/2025 04:00 PM EasternExtended Trading$7.50 -0.04 (-0.60%) As of 10/7/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Journey Medical Stock (NASDAQ:DERM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Journey Medical alerts:Sign Up Key Stats Today's Range$6.91▼$7.6850-Day Range$6.90▼$8.5452-Week Range$3.54▼$8.90Volume217,917 shsAverage Volume98,247 shsMarket Capitalization$198.64 millionP/E RatioN/ADividend YieldN/APrice Target$12.17Consensus RatingHold Company Overview Journey Medical Corp, headquartered in Fairfield, New Jersey, is a commercial dermatology company focused on acquiring, developing and marketing prescription dermatology products in the United States. Since its incorporation in 2019, the company has built a portfolio of both branded and generic topical therapies designed to address a range of skin conditions, including acne, atopic dermatitis, fungal infections and inflammatory lesions. The company’s product lineup features antibiotic/anti-inflammatory combinations and corticosteroid-based formulations delivered through proprietary gel, cream and foam vehicles. Journey Medical leverages an in-house commercial infrastructure, including a specialized sales force and key partnerships with pharmacies and distributors, to reach dermatology practices and healthcare providers nationwide. Underpinning its growth strategy is an acquisition-driven approach that targets established, off-patent dermatology assets with stable prescription demand. The company’s management team, comprised of executives with deep experience in pharmaceutical marketing and specialty drug launches, continues to screen for complementary assets to expand its addressable market and enhance shareholder value.AI Generated. May Contain Errors. Read More Journey Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks29th Percentile Overall ScoreDERM MarketRank™: Journey Medical scored higher than 29% of companies evaluated by MarketBeat, and ranked 785th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingHold Consensus RatingJourney Medical has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 3 buy ratings, no hold ratings, and 2 sell ratings.Upside PotentialJourney Medical has a consensus price target of $12.17, representing about 61.1% upside from its current price of $7.55.Amount of Analyst CoverageJourney Medical has only been the subject of 4 research reports in the past 90 days.Read more about Journey Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Journey Medical are expected to grow in the coming year, from ($1.02) to ($0.23) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Journey Medical is -19.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Journey Medical is -19.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioJourney Medical has a P/B Ratio of 8.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Journey Medical's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted14.77% of the float of Journey Medical has been sold short.Short Interest Ratio / Days to CoverJourney Medical has a short interest ratio ("days to cover") of 9.Change versus previous monthShort interest in Journey Medical has recently increased by 7.86%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldJourney Medical does not currently pay a dividend.Dividend GrowthJourney Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted14.77% of the float of Journey Medical has been sold short.Short Interest Ratio / Days to CoverJourney Medical has a short interest ratio ("days to cover") of 9.Change versus previous monthShort interest in Journey Medical has recently increased by 7.86%, indicating that investor sentiment is decreasing significantly. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 1 people have searched for DERM on MarketBeat in the last 30 days. This is a decrease of -86% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Journey Medical insiders have not sold or bought any company stock.Percentage Held by Insiders15.03% of the stock of Journey Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 7.25% of the stock of Journey Medical is held by institutions.Read more about Journey Medical's insider trading history. Receive DERM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Journey Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DERM Stock News HeadlinesJourney Medical Corp Amends Credit Agreement with SWKSeptember 26, 2025 | tipranks.comSummers Value Partners’ Update on Journey Medical (DERM)September 22, 2025 | insidermonkey.comShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the rights to deliver direct-to-cell service nationwide — a move tech analyst Jeff Brown says could shape the backbone of the coming space economy and create fortunes on a scale not seen since the rise of NVIDIA. | Brownstone Research (Ad)Journey Medical: EMROSI's Ramp Puts Profitability On The HorizonSeptember 6, 2025 | seekingalpha.comJourney Medical Corporation to Participate in September 2025 Investor ConferencesSeptember 3, 2025 | globenewswire.comJourney Medical Corp Enters New Sales AgreementAugust 28, 2025 | tipranks.comHC Wainwright & Co. Initiates Coverage of Journey Medical (DERM) with Buy RecommendationAugust 25, 2025 | msn.comJourney Medical initiated with a Buy at H.C. WainwrightAugust 25, 2025 | msn.comSee More Headlines DERM Stock Analysis - Frequently Asked Questions How have DERM shares performed this year? Journey Medical's stock was trading at $3.91 at the start of the year. Since then, DERM shares have increased by 93.1% and is now trading at $7.55. How were Journey Medical's earnings last quarter? Journey Medical Corporation (NASDAQ:DERM) issued its quarterly earnings results on Tuesday, August, 12th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by $0.09. The firm earned $15.01 million during the quarter, compared to the consensus estimate of $14.93 million. Journey Medical had a negative net margin of 15.49% and a negative trailing twelve-month return on equity of 48.69%. Read the conference call transcript. When did Journey Medical IPO? Journey Medical (DERM) raised $39 million in an initial public offering (IPO) on Friday, November 12th 2021. The company issued 3,520,000 shares at a price of $10.00-$12.00 per share. Who are Journey Medical's major shareholders? Top institutional investors of Journey Medical include Salem Investment Counselors Inc. (0.05%). Insiders that own company stock include Claude Maraoui, Ramsey Alloush, Lindsay A Md Rosenwald, Justin Adam Smith and Joseph Benesch. View institutional ownership trends. How do I buy shares of Journey Medical? Shares of DERM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Journey Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Journey Medical investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), Meta Platforms (META), ServiceNow (NOW), Adobe (ADBE) and AppLovin (APP). Company Calendar Last Earnings8/12/2025Today10/08/2025Next Earnings (Estimated)11/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:DERM Previous SymbolNASDAQ:DERM CIK1867066 Webjourneymedicalcorp.com Phone480-434-6670FaxN/AEmployees90Year Founded2014Price Target and Rating Average Price Target for Journey Medical$12.17 High Price Target$13.00 Low Price Target$10.50 Potential Upside/Downside+61.1%Consensus RatingHold Rating Score (0-4)2.20 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$14.67 million Net Margins-15.49% Pretax Margin-15.28% Return on Equity-48.69% Return on Assets-11.26% Debt Debt-to-Equity Ratio1.11 Current Ratio1.27 Quick Ratio0.95 Sales & Book Value Annual Sales$56.13 million Price / Sales3.54 Cash FlowN/A Price / Cash FlowN/A Book Value$0.91 per share Price / Book8.30Miscellaneous Outstanding Shares26,310,000Free Float22,356,000Market Cap$198.64 million OptionableN/A Beta0.79 Social Links These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:DERM) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored"I'm risking my reputation on this"My prediction: Q4 2025 won't just be another seasonal crypto pump. It will be the quarter that sparks a crypto...Crypto 101 Media | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.